The month ahead: November’s upcoming events
Conferences ramp up, and ASH abstracts near.
Conferences ramp up, and ASH abstracts near.
Novartis' Jakafi faces competition from GSK's momelotinib, while Astra looks over its shoulder at Merck in biliary tract cancer.